Entasis Therapeutics Holdings, Inc.

Entasis Therapeutics Holdings, Inc.

Entasis Therapeutics Holdings, Inc.

Overview
Date Founded

2018

Headquarters

35 Gatehouse Park Drive,Waltham, MA 02451

Type of Company

Public

Employees (Worldwide)

47

Industries

Biotechnology

Company Description

Entasis Therapeutics Holdings, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery and development of novel antibacterial products for serious drug-resistant bacterial infections. Its anti-infective discovery platform has produced a pipeline of differentiated programs, which is bacterial infections, including ETX2514SUL (targeting Acinetobacter baumannii infections), ETX0282CPDP (targeting Enterobacteriaceae infections), Non-Beta-lactam PBP inhibitor, and Zoliflodacin. The company was founded in May 2015 and is headquartered in Waltham, MA.

Website

http://www.entasistx.com

Contact Data
Trying to get in touch with decision makers at Entasis Therapeutics Holdings, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
In The News
GlobeNewswire
January 26, 2021
Entasis Therapeutics Announces Sulbactam-Durlobactam Expanded Access Program for Patients in the U.S.
GlobeNewswire
January 7, 2021
Entasis Therapeutics to Present at the H.C. Wainwright BioConnect 2021 Conference
GlobeNewswire
November 17, 2020
Entasis Therapeutics to Participate in A.G.P.’s Virtual Healthcare Symposium
SEC
November 5, 2020
Entasis Therapeutics Holdings, Inc. filed form 10-Q
GlobeNewswire
November 5, 2020
Entasis Therapeutics Reports Third Quarter 2020 Financial Results and Provides a Business Update

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.
Executives & Employees
See More
Manoussos Perros

President, Chief Executive Officer & Director

Elizabeth M. Keiley

General Counsel

John Mueller

Chief Development Officer

Ruben Tommasi

Chief Scientific Officer

David Altarac

Chief Medical Officer

Michael Gutch

Chief Financial Officer, Principal Accounting Officer & Chief Business Officer

Kyle Dow

Director-Business Development

Board of Directors
David D. Meek

President & Chief Executive Officer-Fergene at Ferring Pharmaceuticals, Inc.

Heather Preston

Managing Partner at Pivotal Bioventure Partners Investment Advisor LLC

David Hastings

Chief Financial & Accounting Officer at Arbutus Biopharma Corp.

Manoussos Perros

President, Chief Executive Officer & Director at Entasis Therapeutics Holdings, Inc.

Heather Behanna

Research Associate at University of Michigan

Howard Mayer

Executive Vice President & Head of Research & Development at Ipsen SA

Trending People
US International Trade Commission
Deal between Korean battery firms is a big lift for US EV makers - CNN
Manchester United Football Club Ltd.
Manchester United hoping Edinson Cavani extends Premier League stay, says Ole Gu... - The Independent UK
United States Department of Commerce
Intel Issues Public Comment on Bureau of Industry & Security Notice - Targeted News Service
Republican Party
Republican state lawmakers push new criminal penalties for election activities - CNN
The Republican National Committee, Inc.
Trump: His brand key to success - St. Louis Post-Dispatch (Missouri)
Trending Organizations
US International Trade Commission
Deal between Korean battery firms is a big lift for US EV makers - CNN
Manchester United Football Club Ltd.
Manchester United hoping Edinson Cavani extends Premier League stay, says Ole Gu... - The Independent UK
United States Department of Commerce
Intel Issues Public Comment on Bureau of Industry & Security Notice - Targeted News Service
Republican Party
Republican state lawmakers push new criminal penalties for election activities - CNN
The Republican National Committee, Inc.
Trump: His brand key to success - St. Louis Post-Dispatch (Missouri)
Paths to Entasis Therapeutics Holdings, Inc.
Potential Connections via
Relationship Science
You
Entasis Therapeutics Holdings, Inc.
Owners & Shareholders
Details Hidden
Pivotal Bioventure Partners Investment Advisor LLC

Pivotal Bioventure Partners seeks invests in companies located in the US and Europe. The firm target companies operating in the fields of biotechnology, innovative therapeutic products. It provide financing for seed, early and later-stage capital requirements.

Details Hidden
Pivotal Bioventure Partners Investment Advisor LLC

Pivotal Bioventure Partners seeks invests in companies located in the US and Europe. The firm target companies operating in the fields of biotechnology, innovative therapeutic products. It provide financing for seed, early and later-stage capital requirements.

Recent Transactions
Details Hidden

Entasis Therapeutics Holdings, Inc. issued USD Common Stock

Transaction Advisors
Underwriter
BMO Capital Markets Corp. (Broker)

Advised onEntasis Therapeutics Holdings, Inc. issued USD Common Stock

Escrow Agent
Computershare Trust Co., NA

Advised onEntasis Therapeutics Holdings, Inc. issued USD Common Stock

Underwriter
Credit Suisse Securities (USA) LLC (Broker)

Advised onEntasis Therapeutics Holdings, Inc. issued USD Common Stock

Associate
Asheley Walker

Advised onEntasis Therapeutics Holdings, Inc. issued USD Common Stock

Legal Advisor
Brent B. Siler

Advised onEntasis Therapeutics Holdings, Inc. issued USD Common Stock

Legal Advisor
Brian Leaf

Advised onEntasis Therapeutics Holdings, Inc. issued USD Common Stock
Clients
Zai Lab Ltd.

Zai Lab Ltd. is a biopharmaceutical company. It engages in the discovering, licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need in the fields of oncology, infectious, and autoimmune diseases. The firm's products include Zejula and Optune. The company was founded by Samantha Ying Du and Marietta Wu in April 2014 and is headquartered in Shanghai, China.
Key Stats and Financials As of 2019
Market Capitalization
$122M
Total Enterprise Value
$26.2M
Earnings Per Share
$-3.33
Debt TEV
0.07x
TEVNet Income
-0.6x
Enterprise Value / Sales
3.75x
Total Equity
$42.2M
Total Debt
$1.83M
EBITDAMargin
-668.49%
EBITDA
$-46.8M
Net Profit
$-43.8M
Revenue
$7M
Investors
Details Hidden
Pivotal Bioventure Partners Investment Advisor LLC

Pivotal Bioventure Partners seeks invests in companies located in the US and Europe. The firm target companies operating in the fields of biotechnology, innovative therapeutic products. It provide financing for seed, early and later-stage capital requirements.

Details Hidden
TPG Biotech

TPG Biotech is a life science venture capital platform of TPG Capital. TPG Biotech focuses on therapeutics, medical devices, and healthcare services. By leveraging TPG's global network to support portfolio companies, TPG Biotech provides access to opportunities and operational experts from other platforms. They target investments globally with a particular focus on opportunities in North America & Asia Pacific, and provides financing for early & later stage capital requirements.

Details Hidden
Novo Ventures 1 A/S

Novo Ventures is an active manager which provides funding for early and later-stage capital requirements, and provides management support. The firm invests in both public and private companies from Northern Europe and the United States. Novo Ventures targets companies operating in the health technology and health services sector, and industries such as biotechnology and medical specialties. It looks to take minority stake positions in its investments, as well as a seat on the board.

Competitors
Merck & Co., Inc. Pharmaceuticals - Kenilworth, NJ

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

GlaxoSmithKline Plc Pharmaceuticals - Brentford, Gbr

GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals, Vaccines, Consumer Healthcare, and Corporate Executive Team (CET). The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The CET segment refers to the management of business activities. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Melinta Therapeutics, Inc. Pharmaceuticals - New Haven, CT

Melinta Therapeutics, Inc. operates as a commercial-stage pharmaceutical company which engages in developing and commercializing anti-infective s for the hospital and selected non-hospital or communities. It markets antibiotics including Baxdela, Vabomere, Orbactiv, and Minocin for injections. These antibiotics are used in the treatment of infections caused by various bacterial diseases. The company was founded by William L. Jorgensen, Peter Moore, and Thomas A. Steitz in October 2000 is headquartered in Morristown, NJ.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Entasis Therapeutics Holdings, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Entasis Therapeutics Holdings, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Entasis Therapeutics Holdings, Inc..